Gateway Investment Advisers LLC Pfizer Inc Transaction History

Gateway Investment Advisers LLC

$8.73 Billion
Q1 2024

A detailed history of Gateway Investment Advisers LLC transactions in Pfizer Inc stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 1,355,907 shares of PFE stock, worth $37.9 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

1,355,907

Previous 1,362,087 0.45%

Holding current value

$37.9 Million

Previous $39.2 Million 4.05%

% of portfolio

0.43%

Previous 0.46%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	SELL	$25.89 - $29.73 $160,000 - $183,731	-6,180 Reduced 0.45%	1,355,907 $37.6 Million
Q4 2023 Jan 09, 2024	SELL	$26.13 - $33.94 $1.37 Million - $1.79 Million	-52,604 Reduced 3.72%	1,362,087 $39.2 Million
Q3 2023 Oct 19, 2023	SELL	$32.09 - $37.51 $1.7 Million - $1.99 Million	-53,005 Reduced 3.61%	1,414,691 $46.9 Million
Q2 2023 Jul 13, 2023	SELL	$36.12 - $41.79 $2.02 Million - $2.34 Million	-55,977 Reduced 3.67%	1,467,696 $53.8 Million
Q1 2023 Apr 11, 2023	SELL	$39.39 - $51.28 $617,753 - $804,224	-15,683 Reduced 1.02%	1,523,673 $62.2 Million

Q4 2022 Jan 13, 2023	SELL	$41.75 - $54.5 $2.78 Million - $3.63 Million	-66,582 Reduced 4.15%	1,539,356 $0
Q3 2022 Oct 07, 2022	SELL	$43.76 - $53.42 $5.97 Million - $7.28 Million	-136,362 Reduced 7.83%	1,605,938 $70.3 Million
Q2 2022 Jul 13, 2022	BUY	$46.53 - $55.17 $2.01 Million - $2.38 Million	43,091 Added 2.54%	1,742,300 $91.3 Million
Q1 2022 Apr 14, 2022	BUY	$45.75 - $56.69 $1.28 Million - $1.58 Million	27,910 Added 1.67%	1,699,209 $88 Million
Q4 2021 Jan 14, 2022	SELL	$41.32 - $61.25 $2.87 Million - $4.26 Million	-69,474 Reduced 3.99%	1,671,299 $98.7 Million
Q3 2021 Oct 22, 2021	BUY	$39.25 - $50.42 $70,061 - $89,999	1,785 Added 0.1%	1,740,773 $74.9 Million
Q2 2021 Jul 13, 2021	SELL	$35.91 - $40.68 $380,717 - $431,289	-10,602 Reduced 0.61%	1,738,988 $68.1 Million
Q1 2021 Apr 14, 2021	SELL	$33.49 - $37.77 $2.28 Million - $2.57 Million	-68,093 Reduced 3.75%	1,749,590 $63.4 Million
Q4 2020 Jan 14, 2021	SELL	$33.47 - $42.56 $6.75 Million - $8.58 Million	-201,572 Reduced 9.98%	1,817,683 $66.9 Million
Q3 2020 Oct 19, 2020	SELL	$31.75 - $37.25 $729,646 - $856,042	-22,981 Reduced 1.13%	2,019,255 $74.1 Million
Q2 2020 Jul 15, 2020	SELL	$30.12 - $36.54 $11.1 Million - $13.5 Million	-370,150 Reduced 15.34%	2,042,236 $66.8 Million
Q1 2020 Apr 13, 2020	BUY	$27.03 - $38.62 $541,410 - $773,558	20,030 Added 0.84%	2,412,386 $78.7 Million
Q4 2019 Jan 09, 2020	SELL	$32.92 - $37.36 $2.53 Million - $2.88 Million	-76,995 Reduced 3.12%	2,392,356 $93.7 Million
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $10.5 Million - $13.6 Million	-323,685 Reduced 11.59%	2,469,351 $88.7 Million
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $4.71 Million - $5.29 Million	-127,487 Reduced 4.37%	2,793,036 $121 Million
Q1 2019 Apr 10, 2019	SELL	$37.5 - $41.2 $2.38 Million - $2.62 Million	-63,484 Reduced 2.13%	2,920,523 $124 Million
Q4 2018 Jan 14, 2019	BUY	$38.47 - $43.86 $686,766 - $782,988	17,852 Added 0.6%	2,984,007 $130 Million
Q3 2018 Oct 16, 2018	SELL	$34.47 - $41.81 $1.33 Million - $1.62 Million	-38,698 Reduced 1.29%	2,966,155 $131 Million
Q2 2018 Jul 11, 2018	SELL	$32.98 - $35.16 $5.23 Million - $5.58 Million	-158,710 Reduced 5.02%	3,004,853 $109 Million
Q1 2018 Apr 12, 2018	SELL	$31.91 - $37.02 $655,048 - $759,946	-20,528 Reduced 0.64%	3,163,563 $112 Million
Q4 2017 Jan 17, 2018	SELL	$33.26 - $35.29 $1.08 Million - $1.15 Million	-32,535 Reduced 1.01%	3,184,091 $115 Million
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $99.7 Million - $110 Million	3,216,626	3,216,626 $115 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Pfizer Inc Transaction History